Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9,614,000
-
Total 13F shares
-
21,695,406
-
Share change
-
-49,498
-
Total reported value
-
$59,443,068
-
Put/Call ratio
-
55%
-
Price per share
-
$2.74
-
Number of holders
-
73
-
Value change
-
-$97,736
-
Number of buys
-
34
-
Number of sells
-
20
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q1 2024
As of 31 Mar 2024,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,695,406 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Propel Bio Management, LLC, Simplify Asset Management Inc., BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.